Expanding Innovation Portfolio to Support Delivering Hearing to Patients in Innovative Ways WHITE BEAR LAKE, Minnesota, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. ("Envoy Medical") (NASDAQ: "COCH"), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that it recently has been awarded three additional patents. These patents are further evidence of Envoy Medical's determination to be an innovation leader in hearing health to benefit patients with si ...

During the periods presented, we did not have, nor do we currently have, any off-balance sheet arrangements as defined under the rules and regulations of the SEC. Our related party arrangements consist of leasing our headquarters office space from a stockholder, receiving loan financings from stockholders. We also recorded a payable to a stockholder on our condensed consolidated balance sheets as of September 30, 2023. For further information on the related party arrangements refer to Note 5 "Restricted Cas ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number - 001-40133 Anzu Special Acquisition Corp I (Exact name of registrant as specified in its charter) Securities registered pursu ...

Concurrently with the execution of the Business Combination Agreement, the Company entered into (A) a Sponsor Support and Forfeiture Agreement with the Sponsor and Envoy pursuant to which, among other things, the Sponsor agreed to vote in favor of the Proposed Business Combination and, subject to and upon the Closing, forfeit all of the 12,500,000 outstanding Anzu private placement warrants and a number of shares of Class B common stock held by the Sponsor as determined pursuant to the Sponsor Support Agree ...

ANZU SPECIAL ACQUISITION CORP I | --- | --- | --- | |------------|------------------------------------------------------------------------------------------------------------------|-------| | | | Page | | | PART I | | | Item 1. | Business. | 5 | | Item 1A. | Risk Factors. | 23 | | Item 1B. | Unresolved Staff Comments. | 56 | | Item 2. | Properties. | 56 | | Item 3. | Legal Proceedings. | 56 | | Item 4. | Mine Safety Disclosures. | 56 | | | PART II | | | Item 5. | Market for Registrant's Common Equity, Relat ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number - 001-40133 Anzu Special Acquisition Corp I (Exact name of registrant as specified in its charter) | --- | --- | --- | -- ...

Table of Contents Title of each class Trading Symbol Name of each exchange on which registered Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant ANZUU The Nasdaq Stock Market LLC Class A common stock, par value $0.0001 per share ANZU The Nasdaq Stock Market LLC Redeemable Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share ANZUW The Nasdaq Stock Market LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number - 001-40133 Anzu Special Acquisition Corp I (Exact name of registrant as specified in its charter) | --- | --- | --- | --- | ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40133 Anzu Special Acquisition Corp I (Exact name of registrant as specified in its charter) Delaware 86-1369123 ( ...

Table of Contents Title of each class Trading Symbol Name of each exchange on which registered Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant ANZUU The Nasdaq Stock Market LLC Class A common stock, par value $0.0001 per share ANZU The Nasdaq Stock Market LLC Redeemable Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share ANZUW The Nasdaq Stock Market LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION ...